Navigation Links
YM BioSciences Reports Fiscal Second Quarter 2011 Operational and Financial Results
Date:2/10/2011

will generate positive efficacy and safety data in future clinical trials; that YM and its various partners will complete their respective clinical trials within the timelines communicated in this release. Except as required by applicable securities laws, we undertake no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.

Summary financial statements attached:

YM BIOSCIENCES INC. Interim Consolidated Balance Sheets (Expressed in Canadian dollars, unless otherwise noted) ------------------------------------------------------------------------- December 31, June 30, 2010 2010 ------------------------------------------------------------------------- (Unaudited) Assets Current assets: Cash and cash equivalents $ 25,261,196 $ 19,460,141 Short-term deposits 53,451,681 26,184,991 Accounts receivable 203,163 161,184 Prepaid expenses 494,678 237,962 ----------------------------------------------------------------------- 79,410,718 46,044,278 Property and equipment 109,065 84,775 Intangible assets 9,391,706 11,645,714 ------------------------------------------------------------------------- $ 88,911,489 $ 57,774,767 ------------------------------------------------------------------------- ------------------------------------------------------------------------- Liabilities and Shareholders' Equity Current liabilities: Accounts payable $ 1,411,962 $ 699,277 Accrued liabilities 3,524,184 2,085,824 Deferred revenue 594,072 1,523,916 ----------------------------------------------------------------------- 5,530,218 4,309,017 Deferred revenue 2,128,758 1,650,909 Shareholders' equity: Share capital 248,203,430 203,498,239 Share purchase warrants 1,378,324 1,473,246 Contributed surplus 14,916,826 14,088,671 Deficit (183,246,067) (167,245,315) ----------------------------------------------------------------------- 81,252,513 51,814,841 Basis of presentation Commitments -------------
'/>"/>

SOURCE YM BioSciences Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related biology technology :

1. Sangamo BioSciences Reports Fourth Quarter and Full Year 2010 Financial Results
2. Sangamo BioSciences Announces Fourth Quarter and Full Year 2010 Conference Call and Webcast
3. YM BioSciences Announces Data from Nimotuzumab Phase II Gastric Cancer Trial Reported at ASCO GI Symposium
4. Ardea Biosciences Prices Public Offering of Common Stock
5. Ardea Biosciences Announces Positive Top-Line Results from Phase 2b Combination Study of RDEA594 in Allopurinol-Refractory Gout Patients
6. Sangamo BioSciences Announces Presentation at J.P. Morgan Healthcare Conference
7. Whitney M. Young, Jr. Health Services and Magellan Biosciences Partner to Provide Three-Minute LeadCare II Blood-Lead Screenings to Berlin Elementary Students
8. YM BioSciences Closes Public Offering of Common Shares
9. YM BIOSCIENCES PRICES $40 MILLION PUBLIC OFFERING
10. Pacific Biosciences and Harvard scientists decode genome of Haitian cholera pathogen
11. Sangamo BioSciences Announces Data Presentation of First In Vivo Demonstration of ZFN-mediated Gene Correction Via Systemic Delivery at American Society for Hematology Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2015)... , Aug. 28, 2015 /PRNewswire/ - RepliCel Life ... regenerative medicine company focused on the development of ... the quarter ended June 30, 2015, corporate highlights, ... management report are available at www.sedar.com ,  ... "RepliCel expects to launch its ...
(Date:8/27/2015)... VA (PRWEB) , ... August 27, 2015 , ... ... contractors solve complex business problems, is pleased to announce their ranking as one of ... annual ranking of the fastest-growing private companies across the nation. , “It is truly ...
(Date:8/27/2015)... , Aug. 27, 2015  Asterias Biotherapeutics, Inc. ... emerging field of regenerative medicine, today announced that executives ... in the month of September.  , ... at Rodman & Renshaw,s 17th Annual Global Investment Conference ... at the St. Regis Hotel in New ...
(Date:8/27/2015)... ... , ... Inc. Magazine released its annual list of the 5,000 fastest-growing privately ... for the three years through 2014. Being named to the Inc. 5000 list designates ... country. , “We are thrilled to make the Inc. 5000 list for 2015,” ...
Breaking Biology Technology:RepliCel Reports Second Quarter 2015 Financial Results 2RepliCel Reports Second Quarter 2015 Financial Results 3RepliCel Reports Second Quarter 2015 Financial Results 4RepliCel Reports Second Quarter 2015 Financial Results 5Capital Edge Consulting Makes Inc. 5000 List of America’s Fastest-Growing Private Companies 2Capital Edge Consulting Makes Inc. 5000 List of America’s Fastest-Growing Private Companies 3Asterias Biotherapeutics to Present at Upcoming Investor Conferences 2iLab Solutions Named to 2015 Inc. 5000 List 2iLab Solutions Named to 2015 Inc. 5000 List 3
... in three years, the Best of State Program,s, ... company in the Medical Innovation category, , , ... LLC (ABL), developer of a new class of products based on ... has won the 2009 Utah Best of State award in the ...
... SAN DIEGO, June 5, 2009 Arena Pharmaceuticals, Inc. (Nasdaq: ... scheduled to present at the 8th Annual Needham Life Sciences Conference ... Pacific Time) at the New York Palace Hotel in ... Chief Financial Officer, is scheduled to provide an overview of the ...
... Expansion in Medical Imaging Management , For Hospitals, ... June 4 Optimal Reading Services Group, Inc., a ... hospitals, imaging centers and radiology groups, announced today that ... substantial investment in Optimal. The investment provides Optimal with ...
Cached Biology Technology:American Biotech Labs(R) Garners 2009 Utah Best of State Award 2American Biotech Labs(R) Garners 2009 Utah Best of State Award 3Arena Pharmaceuticals to Present at the 8th Annual Needham Life Sciences Conference 2Arena Pharmaceuticals to Present at the 8th Annual Needham Life Sciences Conference 3Optimal Reading Services Group, Inc. Receives Investment from Health Evolution Partners 2Optimal Reading Services Group, Inc. Receives Investment from Health Evolution Partners 3
(Date:8/3/2015)... SAN JOSE, Calif. , Aug. 3, 2015 /PRNewswire/ ... developer of human interface solutions, today announced that members ... investment community at the Pacific Crest Global Technology Leadership ... Mountain Time. The conference will be held at the ... The presentation may include forward-looking information. ...
(Date:7/31/2015)... , Chine, 31 juillet 2015 La ... www.icg-10.org ) sera organisée par le BGI du ... Shenzhen en Chine. La ... son inauguration en 2006, l,ICG est devenue l,une ... le domaine des « omiques » et c,est aussi la ...
(Date:7/31/2015)... The 10 th International Conference on Genomics ... 22-25, 2015, in Shenzhen , ... 10 th anniversary this year. Since its inauguration in ... annual meetings in the ,omics, fields, and is one of ... ICG-10 focuses on recent breakthroughs and advances in ,omics, ...
Breaking Biology News(10 mins):La 10e International Conference on Genomics (ICG-10) doit s'ouvrir en octobre 2La 10e International Conference on Genomics (ICG-10) doit s'ouvrir en octobre 3The 10th International Conference on Genomics (ICG-10) to Open in October 2
... form of nanoparticles has been designed by Northwestern Medicine scientists to ... on cancer. This is the first cancer drug tested while in ... test. The scientists designed ... a chemotherapy drug to fertility and can be easily used to ...
... Scientists at the University of Liverpool are embarking on a ... warming on the ecosystems of the seas surrounding North West ... that shelf-seas the seas surrounding continental land masses - ... warming of the seas might affect it. The study ...
... University of Florida study of nearly 5,000 Haiti bird ... arrival 6,000 years ago didn,t cause the island,s birds ... became displaced during a mass extinction event following the ... evidence shows some species were more resilient than others. ...
Cached Biology News:New chemo drug gentler on fertility, tougher on cancer 2New chemo drug gentler on fertility, tougher on cancer 3Scientists awarded £3M to study the way Northwest European seas absorb carbon 2UF fossil bird study on extinction patterns could help today's conservation efforts 2UF fossil bird study on extinction patterns could help today's conservation efforts 3
solute carrier family 25, member 13 (citrin)...
poliovirus receptor-related 2 (herpesvirus entry mediator B), mRNA...
CREB-2 (H-290)...
Anti-Dynamin Monoclonal Antibody Description: 100 g Research Focus: neuroscience Storage: -20C Shipping Temperature: 4C...
Biology Products: